Molecular expression analysis of different inflammatory mediators and their role in breast cancer progression and metastasis
American Journal of Biomedical and Life Sciences
Volume 3, Issue 2-3, April 2015, Pages: 16-20
Received: Dec. 7, 2014; Accepted: Dec. 9, 2014; Published: Aug. 7, 2015
Views 3987      Downloads 116
Authors
Aula Ammar, Department of Biochemistry and Microbiology, School of Pharmacy, Tishreen University, Latakia, Syria
Amani Halabi, Department of Biochemistry and Microbiology, School of Pharmacy, Tishreen University, Latakia, Syria
Zuheir Al-Shehabi, Department of Pathology, School of Medicine, Tishreen University, Latakia, Syria
Article Tools
Follow on us
Abstract
Introduction: Cytokines include different subfamilies such as interleukins (IL), chemokines, and growth factors. They play an important role in inflammatory conditions such as cancer progression and metastasis. There is an increasing interest in developing strategies to antagonize the function of some cytokine/chemokine to interfere with tumor progression and metastasis, the leading cause of death in most patients. The aim of the research project is to study the molecular characteristics of a sample of Syrian patients with breast cancer and assess the protein and gene expression of different inflammatory mediators and correlate that with the clinicopathological criteria of tumors. Materials and methods: Patient samples will be evaluated histologically (H&E stain) and stained immunohistochemically with antibodies against important molecular markers, cytokines, and different types of activated leukocytes. Immunohistochemistry of CD206, a marker of alternatively activated macrophages in tumors is shown here. PCR and immunohistochemical analysis of cytokines (e.g. IL-2, GM-CSF, IFNγ, M-CSG, IL-4, IL-10, CXCL8, CXCL12, CCL21, CCL19, CCR7) will be further implemented. The staining intensity, localization and distribution within the tumor will be examined and correlated with the gene expression and other clinnicopathological information. Expected results: We expect to get new information about the role of different cytokines in breast cancer progression in addition to get an insight into the possible inter-relationship between these cytokines.
Keywords
Breast Cancer, Tumor Environment, Lymph Node Metastasis, Cytokines, Chemokines, Insert
To cite this article
Aula Ammar, Amani Halabi, Zuheir Al-Shehabi, Molecular expression analysis of different inflammatory mediators and their role in breast cancer progression and metastasis, American Journal of Biomedical and Life Sciences. Special Issue: Spectral Imaging for Medical Diagnosis “Modern Tool for Molecular Imaging”. Vol. 3, No. 2-3, 2015, pp. 16-20. doi: 10.11648/j.ajbls.s.2015030203.13
References
[1]
J.M. Herendeen, and C Lindley “Use of NSAIDs for the chemoprevention of colorectal cancer,” Ann Pharmacother. Vol. 37, pp.1664-1674, 2003.
[2]
H.E. Dvorak, “Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing,” N Engl J Med. Vol. 315(26), pp.1950-1959, 1986.
[3]
M Karin, “NF-κβ and cancer: mechanisms and targets,” Mol carcinog. Vol. 45, pp.355-361, 2006.
[4]
W Lin, and M Karin, “A cytokine-mediated link between innate immunity, inflammation, and cancer,” J. Clin. Invest. Vol. 117, pp.1175–1183, 2007.
[5]
O.J. Sculy, B.H. Bay, G Yip, and Y Yu, “Breast cancer metastasis,” Cancer Genomics & Proteomics. Vol. 9, pp. 311-320, 2012.
[6]
F. Balkwill and A. Mantovani, “Inflammation and cancer: back to Virchow?” Lancet. Vol. 357, pp. 539-545, 2001.
[7]
R. M. Strieter, “Chemokines: not just leukocyte chemoattractants in the promotion of cancer,” Nat Immunol. Vol. 2, pp. 285-6, 2001.
[8]
M. P. Keane, J. A. Belperio, Y.Y. Xue, and M. D. Burdick, “Depletion of CXCR2 inhibits tumor Growth and Angiogenesis in a Murine Model of Lung Cancer,” J Immunol. Vol. 172, pp. 2853–2860, 2004.
[9]
H Takeuchi, A Fujimoto, M Tanaka, TT Yamano, and E Hsueh, “CCL21 Chemokine Regulates Chemokine Receptor CCR7 Bearing Malignant Melanoma Cells”, Clin Cancer Res. Vol. 10, pp. 2351–2358, 2004.
[10]
L. Y. Feng, Z. L. Ou, F.Y. Wu, Z.Z. Shen, Z. M. Shao, “Involvement of a Novel Chemokine Decoy Receptor CCX-CKR in Breast Cancer Growth, Metastasis and Patient Survival,” Clin Cancer Res. Vol. 15(9), pp. 2962-2970, 2012.
[11]
M. Razmkhah, M Jaberipour, A. Safaei, A. R. Talei, N. Erfani, A. Ghaderi, “Chemokine and chemokine receptors: a comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients,” Eur. Cytokine Netw. Vol. 33 (3), pp. 72-7, 2012.
[12]
D. A. Porter, I. E. Krop, S. Nasser, D. Sgroi, C. M. Kaelin, J. R. Marks, et al, “A SAGE (Serial Analysis of Gene Expression) view of breast tumor progression,” Cancer Res. Vol. 61, pp. 5697-5702, 2001.
[13]
J. E. Talmadge, M Donkor, and E. Scholar, “Inflammatory cell infiltration of tumors: Jekyll or Hyde,” Cancer Metastatis Rev. Vol. 26, pp. 373-400, 2007.
[14]
A. Sica, A. Saccani, and A. Mantovani, “Tumor-associated macrophages: a molecular perspective,” Int Immunopharmacol. Vol. 2(8), pp.1045-1054, 2002.
[15]
J. Shih, Y. Ang, J.W. Jeremy, and Y. Pan-Chyr, “Tumor-associated macrophage: Its role in cancer invasion and metastasis,” J. Cancer Mol. Vol. 2(3), pp. 101-106, 2006.
[16]
Q. W. Zhang, L. Lie, C. Y. Gong, H. S. Shi, Y. H. Zeng, X. Z. Wang, et al, “Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature,”. Plos one. Vol. 7(12), pp. 1-14, 2012.
[17]
R. A. Mohammed, S. G. Martin, A. M Mahmmod, R. D. Macmillan, A. R. Green, et al, “Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up,” J Pathol. Vol. 223, pp. 358-65, 2011.
[18]
Y. Liu, R. Ji, J. Li, Q. Gu, X. Zhao, T. Sun, et al, “Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis,” J Exp Clin Cancer Res. Vol. 29, pp. 1-16, 2010.
[19]
Y. Ding, Y. Shimada, M. Maeda, A. Kawabe, J. Kaganoi, I. Komoto, et al, “Association of CC Chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma,” Clin Cancer Res. Vol. 9, pp. 3406-3412, 2003.
[20]
M. Karin M, “NF-κβ and cancer: mechanisms and targets,” Mol carcinog. Vol. 45, pp. 355-361, 2006.
[21]
V. Gocheva, W. Zeng, D.Ke, D. Klimstra, T. Reinheckel, C. Peters, et al, “Distinct roles for cysteine cathepsin genes in multistage tumorigenesis,” Genes Dev. Vol. 20(5), pp. 543-556, 2006.
[22]
A. Ammar, M. Blal, A. Halabi, Z. Al-shehabi, “A comparative immunohistochemical analysis of cathepsins B and S in human breast cancer,” Clin Cancer Investig J. Vol. 3(5), pp. 388-393, 2014.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186